Safety and Efficacy of Two Oral Tinidazole Regimens for Refractory Trichomonas Vaginitis

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-55

SponsorShangrong Fan

About this trial

We compare two oral tinidazole regimens for refractory trichomonas vaginitis.

Women be at least 18 years of age

Failure of conventional treatment (recommended by guidelines including tinidazole, 2g once daily for 5-7 days)

Allergy to metronidazole or tinidazol

Pregnant or nursing

HIV or other chronic disease

20 Participants

are divided into 2 treatment groups

Shangrong Fan

Lead sponsor

Peking University Shenzhen Hospital

Sponsor institution